NASDAQ: ADPT - Adaptive Biotechnologies Corporation

Rentabilité sur six mois: +56.96%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Calendrier des promotions Adaptive Biotechnologies Corporation

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Adaptive Biotechnologies Corporation

Корпорация Adaptive Biotechnologies, коммерческая компания, разрабатывает платформу иммунной медицины для диагностики и лечения различных заболеваний. Компания предлагает исследовательскую услугу и набор средств иммунного SEQ, которые используются для ответа на исследовательские вопросы, а также для обнаружения новых прогностических и диагностических сигналов. Он также предоставляет диагностические тесты clonoSEQ, которые включают услуги иммуносеквенирования для использования при обнаружении и мониторинге минимальной остаточной болезни у пациентов с некоторыми видами рака крови.

plus de détails
Кроме того, компания предлагает ряд клинических продуктов и услуг, которые используются для диагностики, мониторинга и лечения таких заболеваний, как рак, аутоиммунные и инфекционные заболевания. Корпорация Adaptive Biotechnologies Corporation имеет стратегическое сотрудничество с Genentech, Inc. в области разработки, производства и коммерциализации неоантиген-направленных терапий Т-клетками для лечения ряда видов рака; Корпорация Microsoft разработает диагностические тесты для раннего выявления различных заболеваний на основе одного анализа крови; и Amgen для разработки терапевтического средства для предотвращения или лечения COVID-19. Он обслуживает клиентов, занимающихся исследованиями в области наук о жизни, клинической диагностикой и открытием новых лекарств. Компания ранее называлась Adaptive TCR Corporation, а в декабре 2011 года сменила название на Adaptive Biotechnologies Corporation. Adaptive Biotechnologies Corporation была основана в 2009 году, ее штаб-квартира находится в Сиэтле, штат Вашингтон.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

IPO date 2019-06-27
ISIN US00650F1093
Industry Life Sciences Tools & Services
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.adaptivebiotech.com
Цена ао 7.55
Changement de prix par jour: 0% (7.55)
Changement de prix par semaine: -5.74% (8.01)
Changement de prix par mois: +24.38% (6.07)
Changement de prix sur 3 mois: +35.3% (5.58)
Changement de prix sur six mois: +56.96% (4.81)
Changement de prix par an: +90.66% (3.96)
Evolution du prix sur 3 ans: -34.58% (11.54)
Evolution du prix sur 5 ans: -73.28% (28.26)
Evolution des prix sur 10 ans: 0% (7.55)
Evolution des prix depuis le début de l'année: +20.03% (6.29)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 4.28 4
P/BV 2.37 6
P/E 43.96 4
EV/EBITDA -4.98 0
Total: 5.25

Efficacité

Nom Signification Grade
ROA, % -34.07 0
ROE, % -73.04 0
Total: 0

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -1.28 10
Total: 9

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 100.09 10
Rentabilité Ebitda, % 146.77 10
Rentabilité EPS, % 83.45 9
Total: 7.8
Plus de détails

Date de transaction Date de divulgation Insider Taper Prix Volume Quantité Partagez jusqu'à, % Partager après, % Document
08.10.2024 10.10.2024 BOBULSKY SUSAN
Chief Commercial Officer, MRD		 Achat 1.98 9 900 5000 0 0 lien
10.01.2023 11.01.2023 ADAMS R MARK
Chief Operating Officer		 Vente 8.58 18 275 2130 0 0 lien
09.01.2023 11.01.2023 ADAMS R MARK
Chief Operating Officer		 Vente 8.5 8 458 995 0 0 lien
05.08.2022 05.08.2022 SOOD NITIN
Chief Commercial Officer, MRD		 Vente 10.98 192 589 17540 0 -0.01 lien
08.07.2022 08.07.2022 ADAMS R MARK
Chief Operating Officer		 Vente 10.47 24 081 2300 0 0 lien
07.07.2022 08.07.2022 ADAMS R MARK
Chief Operating Officer		 Vente 9.53 7 862 825 0 0 lien
07.04.2022 08.04.2022 ADAMS R MARK
Chief Operating Officer		 Vente 13.17 10 944 831 0 0 lien
08.03.2022 10.03.2022 BALDO LANCE
Chief Medical Officer		 Vente 11.43 38 291 3350 0 0 lien
22.12.2021 23.12.2021 Cohen Chad M
Chief Financial Officer		 Vente 30 300 000 10000 0 -0.01 lien
22.12.2021 23.12.2021 Cohen Chad M
Chief Financial Officer		 Achat 7.27 72 700 10000 0 0.01 lien
22.12.2021 23.12.2021 Taylor Stacy L
SVP and General Counsel		 Vente 30 460 140 15338 0 -0.01 lien
22.12.2021 23.12.2021 Taylor Stacy L
SVP and General Counsel		 Achat 6.97 106 906 15338 0 0.01 lien
08.10.2021 08.10.2021 ROBINS HARLAN S
Chief Scientific Officer		 Vente 32.96 128 379 3895 0 0 lien
08.10.2021 08.10.2021 ROBINS HARLAN S
Chief Scientific Officer		 Achat 6.32 24 616 3895 0 0 lien
08.10.2021 08.10.2021 ADAMS R MARK
Chief Operating Officer		 Vente 33.67 60 640 1801 0 0 lien
07.10.2021 08.10.2021 ROBINS HARLAN S
Chief Scientific Officer		 Vente 33.62 130 950 3895 0 0 lien
07.10.2021 08.10.2021 ROBINS HARLAN S
Chief Scientific Officer		 Achat 6.32 24 616 3895 0 0 lien
07.10.2021 08.10.2021 ADAMS R MARK
Chief Operating Officer		 Vente 32.47 42 990 1324 0 0 lien
06.10.2021 08.10.2021 ROBINS HARLAN S
Chief Scientific Officer		 Vente 32.27 125 692 3895 0 0 lien
06.10.2021 08.10.2021 ROBINS HARLAN S
Chief Scientific Officer		 Achat 6.32 24 616 3895 0 0 lien
06.10.2021 07.10.2021 Cohen Chad M
Chief Financial Officer		 Vente 32.3 161 500 5000 0 0 lien
06.10.2021 07.10.2021 Cohen Chad M
Chief Financial Officer		 Achat 7.27 36 350 5000 0 0 lien
05.10.2021 07.10.2021 Cohen Chad M
Chief Financial Officer		 Vente 32.51 162 550 5000 0 0 lien
05.10.2021 07.10.2021 Cohen Chad M
Chief Financial Officer		 Achat 7.27 36 350 5000 0 0 lien
10.09.2021 10.09.2021 ROBINS CHAD M
CEO and Chairman		 Vente 38.38 191 900 5000 0 0 lien
09.09.2021 10.09.2021 ROBINS CHAD M
CEO and Chairman		 Vente 38.42 951 010 24753 0 -0.02 lien
08.09.2021 10.09.2021 ROBINS CHAD M
CEO and Chairman		 Vente 38.45 528 534 13746 0 -0.01 lien
08.09.2021 09.09.2021 Cohen Chad M
Chief Financial Officer		 Vente 39.01 195 050 5000 0 0 lien
08.09.2021 09.09.2021 Cohen Chad M
Chief Financial Officer		 Achat 7.27 36 350 5000 0 0 lien
07.09.2021 09.09.2021 Taylor Stacy L
SVP and General Counsel		 Vente 40 19 800 495 0 0 lien
07.09.2021 09.09.2021 Taylor Stacy L
SVP and General Counsel		 Achat 6.55 3 242 495 0 0 lien
07.09.2021 09.09.2021 Cohen Chad M
Chief Financial Officer		 Vente 39.71 372 281 9375 0 -0.01 lien
07.09.2021 09.09.2021 Cohen Chad M
Chief Financial Officer		 Achat 6.55 61 406 9375 0 0.01 lien
27.08.2021 27.08.2021 ROBINS HARLAN S
Chief Scientific Officer		 Vente 34.78 135 468 3895 0 0 lien
27.08.2021 27.08.2021 ROBINS HARLAN S
Chief Scientific Officer		 Achat 6.32 24 616 3895 0 0 lien
26.08.2021 27.08.2021 ROBINS HARLAN S
Chief Scientific Officer		 Vente 33.89 132 002 3895 0 0 lien
26.08.2021 27.08.2021 ROBINS HARLAN S
Chief Scientific Officer		 Achat 6.32 24 616 3895 0 0 lien
25.08.2021 27.08.2021 ROBINS HARLAN S
Chief Scientific Officer		 Vente 34.09 132 781 3895 0 0 lien
25.08.2021 27.08.2021 ROBINS HARLAN S
Chief Scientific Officer		 Achat 6.32 24 616 3895 0 0 lien
17.06.2021 17.06.2021 ROBINS CHAD M
CEO and Chairman		 Vente 39.53 207 730 5255 0 0 lien
16.06.2021 17.06.2021 ROBINS CHAD M
CEO and Chairman		 Vente 38.13 180 927 4745 0 0 lien
15.06.2021 17.06.2021 ROBINS CHAD M
CEO and Chairman		 Vente 38.27 765 400 20000 0 -0.02 lien
14.06.2021 16.06.2021 GRIFFIN MICHELLE RENEE
Director		 Vente 38.56 96 400 2500 0 0 lien
14.06.2021 16.06.2021 GRIFFIN MICHELLE RENEE
Director		 Achat 7.8 19 500 2500 0 0 lien
11.06.2021 11.06.2021 ROBINS HARLAN S
Chief Scientific Officer		 Vente 38.41 149 607 3895 0 0 lien
11.06.2021 11.06.2021 ROBINS HARLAN S
Chief Scientific Officer		 Achat 6.32 24 616 3895 0 0 lien
10.06.2021 11.06.2021 ROBINS HARLAN S
Chief Scientific Officer		 Vente 37.56 146 296 3895 0 0 lien
10.06.2021 11.06.2021 ROBINS HARLAN S
Chief Scientific Officer		 Achat 6.32 24 616 3895 0 0 lien
09.06.2021 11.06.2021 ROBINS HARLAN S
Chief Scientific Officer		 Vente 35.99 140 181 3895 0 0 lien
09.06.2021 11.06.2021 ROBINS HARLAN S
Chief Scientific Officer		 Achat 6.32 24 616 3895 0 0 lien
14.05.2021 17.05.2021 LO FRANCIS
Chief People Officer		 Vente 33.8 67 600 2000 0 0 lien
14.05.2021 17.05.2021 LO FRANCIS
Chief People Officer		 Achat 7.8 15 600 2000 0 0 lien
12.05.2021 13.05.2021 Cohen Chad M
Chief Financial Officer		 Vente 32.63 326 300 10000 0 -0.01 lien
12.05.2021 13.05.2021 Cohen Chad M
Chief Financial Officer		 Achat 6.55 65 500 10000 0 0.01 lien
11.05.2021 13.05.2021 Cohen Chad M
Chief Financial Officer		 Vente 31.53 315 300 10000 0 -0.01 lien
11.05.2021 13.05.2021 Cohen Chad M
Chief Financial Officer		 Achat 6.55 65 500 10000 0 0.01 lien
06.05.2021 07.05.2021 ROBINS HARLAN S
Chief Scientific Officer		 Vente 35.7 139 052 3895 0 0 lien
06.05.2021 07.05.2021 ROBINS HARLAN S
Chief Scientific Officer		 Achat 6.32 24 616 3895 0 0 lien
05.05.2021 07.05.2021 ROBINS HARLAN S
Chief Scientific Officer		 Vente 35.43 113 199 3195 0 0 lien
05.05.2021 07.05.2021 ROBINS HARLAN S
Chief Scientific Officer		 Achat 6.32 24 616 3895 0 0 lien
04.05.2021 06.05.2021 ROBINS HARLAN S
Chief Scientific Officer		 Vente 36.14 140 765 3895 0 0 lien
04.05.2021 06.05.2021 ROBINS HARLAN S
Chief Scientific Officer		 Achat 6.32 24 616 3895 0 0 lien
30.04.2021 03.05.2021 Taylor Stacy L
SVP and General Counsel		 Vente 41.93 174 680 4166 0 0 lien
30.04.2021 03.05.2021 Taylor Stacy L
SVP and General Counsel		 Achat 15.04 62 657 4166 0 0 lien
15.04.2021 16.04.2021 LO FRANCIS
Chief People Officer		 Vente 43.04 86 080 2000 0 0 lien
15.04.2021 16.04.2021 LO FRANCIS
Chief People Officer		 Achat 7.8 15 600 2000 0 0 lien
14.04.2021 16.04.2021 GRIFFIN MICHELLE RENEE
Director		 Vente 43.41 195 345 4500 0 0 lien
14.04.2021 16.04.2021 GRIFFIN MICHELLE RENEE
Director		 Achat 7.8 35 100 4500 0 0 lien
14.04.2021 16.04.2021 BALDO LANCE
Chief Medical Officer		 Vente 44.5 89 000 2000 0 0 lien
14.04.2021 16.04.2021 BALDO LANCE
Chief Medical Officer		 Achat 7.8 15 600 2000 0 0 lien
31.03.2021 02.04.2021 Taylor Stacy L
SVP and General Counsel		 Vente 40 166 680 4167 0 0 lien
31.03.2021 02.04.2021 Taylor Stacy L
SVP and General Counsel		 Achat 15.04 62 672 4167 0 0 lien
19.03.2021 19.03.2021 ROBINS CHAD M
CEO and Chairman		 Vente 41.97 209 850 5000 0 0 lien
18.03.2021 19.03.2021 ROBINS CHAD M
CEO and Chairman		 Vente 42.55 212 750 5000 0 0 lien
18.03.2021 19.03.2021 Palaniappan Jyoti
SVP, Diagnostics, immunoSEQ Dx		 Vente 43.58 699 546 16052 0 -0.01 lien
18.03.2021 19.03.2021 Palaniappan Jyoti
SVP, Diagnostics, immunoSEQ Dx		 Achat 22.55 361 973 16052 0 0.01 lien
17.03.2021 19.03.2021 ROBINS CHAD M
CEO and Chairman		 Vente 44.16 220 800 5000 0 0 lien
16.03.2021 17.03.2021 GRIFFIN MICHELLE RENEE
Director		 Vente 47 70 500 1500 0 0 lien
16.03.2021 17.03.2021 GRIFFIN MICHELLE RENEE
Director		 Achat 7.8 11 700 1500 0 0 lien
15.03.2021 17.03.2021 LO FRANCIS
Chief People Officer		 Vente 41.83 83 660 2000 0 0 lien
15.03.2021 17.03.2021 LO FRANCIS
Chief People Officer		 Achat 7.8 15 600 2000 0 0 lien
15.03.2021 17.03.2021 BENZENO SHARON
Chief Business Development Off		 Vente 41.69 56 448 1354 0 0 lien
15.03.2021 17.03.2021 BENZENO SHARON
Chief Business Development Off		 Achat 31.71 42 935 1354 0 0 lien
15.03.2021 17.03.2021 GRIFFIN MICHELLE RENEE
Director		 Vente 41.75 187 875 4500 0 0 lien
15.03.2021 17.03.2021 GRIFFIN MICHELLE RENEE
Director		 Achat 7.8 35 100 4500 0 0 lien
10.03.2021 12.03.2021 Cohen Chad M
Chief Financial Officer		 Vente 42.54 425 400 10000 0 -0.01 lien
10.03.2021 12.03.2021 Cohen Chad M
Chief Financial Officer		 Achat 6.32 63 200 10000 0 0.01 lien
25.02.2021 26.02.2021 RUBINSTEIN JULIE
President		 Vente 56.18 824 442 14675 0 -0.01 lien
25.02.2021 26.02.2021 RUBINSTEIN JULIE
President		 Achat 6.55 96 121 14675 0 0.01 lien
24.02.2021 26.02.2021 RUBINSTEIN JULIE
President		 Vente 57.78 866 700 15000 0 -0.01 lien
24.02.2021 26.02.2021 RUBINSTEIN JULIE
President		 Achat 6.55 98 250 15000 0 0.01 lien
18.02.2021 19.02.2021 RUBINSTEIN JULIE
President		 Vente 60.92 913 800 15000 0 -0.01 lien
18.02.2021 19.02.2021 RUBINSTEIN JULIE
President		 Achat 6.55 98 250 15000 0 0.01 lien
17.02.2021 19.02.2021 RUBINSTEIN JULIE
President		 Vente 62.05 930 750 15000 0 -0.01 lien
17.02.2021 19.02.2021 RUBINSTEIN JULIE
President		 Achat 6.55 98 250 15000 0 0.01 lien
11.02.2021 12.02.2021 RUBINSTEIN JULIE
President		 Vente 63.28 949 200 15000 0 -0.01 lien
11.02.2021 12.02.2021 RUBINSTEIN JULIE
President		 Achat 6.55 98 250 15000 0 0.01 lien
10.02.2021 12.02.2021 RUBINSTEIN JULIE
President		 Vente 62.96 944 400 15000 0 -0.01 lien
10.02.2021 12.02.2021 RUBINSTEIN JULIE
President		 Achat 6.55 98 250 15000 0 0.01 lien
04.02.2021 05.02.2021 RUBINSTEIN JULIE
President		 Vente 58.98 884 700 15000 0 -0.01 lien
04.02.2021 05.02.2021 RUBINSTEIN JULIE
President		 Achat 6.32 94 800 15000 0 0.01 lien
03.02.2021 05.02.2021 ROBINS HARLAN S
Chief Scientific Officer		 Vente 59.58 464 128 7790 0 -0.01 lien
03.02.2021 05.02.2021 ROBINS HARLAN S
Chief Scientific Officer		 Achat 6.32 49 233 7790 0 0.01 lien
03.02.2021 05.02.2021 RUBINSTEIN JULIE
President		 Vente 59.76 896 400 15000 0 -0.01 lien
03.02.2021 05.02.2021 RUBINSTEIN JULIE
President		 Achat 6.32 94 800 15000 0 0.01 lien
28.01.2021 29.01.2021 RUBINSTEIN JULIE
President		 Vente 55.83 837 450 15000 0 -0.01 lien
28.01.2021 29.01.2021 RUBINSTEIN JULIE
President		 Achat 6.32 94 800 15000 0 0.01 lien
27.01.2021 29.01.2021 BALDO LANCE
Chief Medical Officer		 Vente 58.95 2 358 000 40000 0 -0.03 lien
27.01.2021 29.01.2021 BALDO LANCE
Chief Medical Officer		 Achat 7.8 312 000 40000 0 0.03 lien
27.01.2021 29.01.2021 RUBINSTEIN JULIE
President		 Vente 58.94 884 100 15000 0 -0.01 lien
27.01.2021 29.01.2021 RUBINSTEIN JULIE
President		 Achat 6.32 94 800 15000 0 0.01 lien
26.01.2021 27.01.2021 RUBINSTEIN JULIE
President		 Vente 64.61 969 150 15000 0 -0.01 lien
20.01.2021 22.01.2021 Cohen Chad M
Chief Financial Officer		 Vente 67.33 3 366 500 50000 0 -0.04 lien
14.01.2021 15.01.2021 GRIFFIN MICHELLE RENEE
Director		 Vente 65.88 395 280 6000 0 0 lien
14.01.2021 15.01.2021 GRIFFIN MICHELLE RENEE
Director		 Achat 7.8 46 800 6000 0 0 lien
14.01.2021 15.01.2021 RUBINSTEIN JULIE
President		 Vente 65.62 984 300 15000 0 -0.01 lien
14.01.2021 15.01.2021 RUBINSTEIN JULIE
President		 Achat 6.32 94 800 15000 0 0.01 lien
13.01.2021 15.01.2021 RUBINSTEIN JULIE
President		 Vente 63.22 948 300 15000 0 -0.01 lien
13.01.2021 15.01.2021 RUBINSTEIN JULIE
President		 Achat 6.32 94 800 15000 0 0.01 lien
31.12.2020 31.12.2020 Taylor Stacy L
SVP and General Counsel		 Vente 57.86 377 826 6530 0 -0.01 lien
31.12.2020 31.12.2020 RUBINSTEIN JULIE
President		 Vente 57.93 868 950 15000 0 -0.01 lien
31.12.2020 31.12.2020 RUBINSTEIN JULIE
President		 Achat 6.32 94 800 15000 0 0.01 lien
31.12.2020 31.12.2020 Taylor Stacy L
SVP and General Counsel		 Achat 7.46 48 714 6530 0 0.01 lien
11.12.2020 11.12.2020 SANG CHARLES
SVP, External Affairs		 Vente 56.13 2 806 500 50000 0 -0.04 lien
10.12.2020 11.12.2020 BOBULSKY SUSAN
SVP, Diagnostics, clonoSEQ		 Vente 55 1 375 000 25000 0 -0.02 lien

Établissements Volume Partager, %
Viking Global Investors, L.P. 29993708 20.67
ARK Investment Management, LLC 12806513 8.83
Vanguard Group Inc 12767684 8.8
Matrix Capital Management 11572590 7.98
Blackrock Inc. 11421554 7.87
Sumitomo Mitsui Trust Holdings, Inc. 6511659 4.49
Nikko Asset Management Americas, Inc. 6511659 4.49
Point72 Asset Management, L.P. 3722500 2.57
Pictet Asset Management Holding SA 3422356 2.36
Aristotle Atlantic Partners, LLC 3050684 2.1

ETF Partager, % Rentabilité pour l'année, % Dividendes, %
ARK Genomic Revolution ETF 3.90587 -8.08 0.05494
ProShares UltraShort Nasdaq Biotechnology 0.42 -40.36 1.76
First Trust Nasdaq Lux Digital Health Solutions ETF 0.29616 30.33 0.06621
iShares Micro-Cap ETF 0.13671 17.09 1.54048
Goldman Sachs Innovate Equity ETF 0.08857 29.66 1.20987
Future Tech ETF 0.06954 426.34 0.8416
Principal Healthcare Innovators ETF 0.06954 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.06786 28.58 0.8565
ProShares Ultra Nasdaq Biotechnology 0.04514 51.7 0.85651
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.02554 31.36 1.41955
Avantis U.S Small Cap Equity ETF 0.02498 27.77 1.68271
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.02245 17.58 1.75869
Vanguard Russell 2000 ETF 0.02 17.16 1.48801
Schwab U.S. Small-Cap ETF 0.01402 17.47 1.51433
ProShares UltraPro Russell2000 0.01164 89.82 1.47873
ProShares Hedge Replication ETF 0.00326 5.92 1.47892
Dimensional U.S. Core Equity 2 ETF 0.0031 30.76 1.47098
Dimensional US Core Equity Market ETF 0.0012 30.98 1.40618
Avantis U.S. Equity ETF 0.00116 23.04 1.59151
iShares Russell 3000 ETF 0.00093 24.83 1.43482
Schwab U.S. Broad Market ETF 0.00085 24.86 1.43354
Dimensional U.S. Equity ETF 0.00061 31.53 1.3557
Avantis Responsible U.S. Equity ETF 0.00002 26.78 1.45257
Vanguard Russell 3000 ETF 0 31.87 1.43817



Superviseur Titre d'emploi Paiement Année de naissance
Ms. Julie Rubinstein President & COO 760.46k 1972 (53 année)
Dr. Harlan S. Robins Ph.D. Co-Founder & Chief Scientific Officer 759.61k 1973 (52 année)
Mr. Christopher Carlson Ph.D. Founder N/A
Karina Calzadilla Vice President of Investor Relations N/A
Mr. Kyle Piskel VP, CFO & Principal Accounting Officer 375.9k 1984 (41 année)
Dr. Sharon Benzeno Ph.D. Chief Commercial Officer of Immune Medicine 671.29k 1974 (51 année)
Ms. Stacy L. Taylor Senior VP, General Counsel & Corporate Secretary N/A 1960 (65 années)
Mr. Chad M. Robins M.B.A. Co-Founder, CEO & Chairman 1.19M 1975 (50 années)
Mr. Francis T. Lo Chief People Officer N/A 1981 (44 année)
Ms. Susan Bobulsky Chief Commercial Officer of MRD 1981 (44 année)

Adresse: United States, Seattle, WA , 1551 Eastlake Avenue East - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: http://www.adaptivebiotech.com